Patents by Inventor Jeffrey F. Fritzen

Jeffrey F. Fritzen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Prodrugs of HIV reverse transcriptase inhibitors
    Patent number: 10004740
    Abstract: Compounds of Formula I are described: wherein R1 and R2 are defined herein. The compounds of Formula I are useful in the inhibition of HIV reverse transcriptase, the prophylaxis and treatment of infection by HIV, and the prophylaxis, delay in the onset or progression, and treatment of AIDS. The compounds can be employed as ingredients in pharmaceutical compositions, optionally in combination with other antivirals, immunomodulators, antibiotics or vaccines.
    Type: Grant
    Filed: March 27, 2015
    Date of Patent: June 26, 2018
    Assignee: Merck Sharp & Dohme Corp.
    Inventors: Christopher S. Burgey, Jeffrey F. Fritzen, Jaume Balsells, Mehul Patel
  • PRODRUGS OF HIV REVERSE TRANSCRIPTASE INHIBITORS
    Publication number: 20170173015
    Abstract: Compounds of Formula I are described: wherein R1 and R2 are defined herein. The compounds of Formula I are useful in the inhibition of HIV reverse transcriptase, the prophylaxis and treatment of infection by HIV, and the prophylaxis, delay in the onset or progression, and treatment of AIDS. The compounds can be employed as ingredients in pharmaceutical compositions, optionally in combination with other antivirals, immunomodulators, antibiotics or vaccines.
    Type: Application
    Filed: March 27, 2015
    Publication date: June 22, 2017
    Applicant: Merck Sharp & Dohme Corp.
    Inventors: Christopher S. Burgey, Jeffrey F. Fritzen, Jaume Balsells, Mehul Patel